CD Diagnostics is a fully integrated diagnostics company with expertise in immunoassay development and commercialization. The company combines expertise in immunoassay development with biomarker research, patented technology, and GMP manufacturing, to deliver a range of products that address challenging diagnostic issues. The company is improving patient outcomes by providing more accurate and rapid diagnosis. CD Diagnostics acquired Citrano Medical Laboratories, a CLIA-certified laboratory that has provided comprehensive clinical testing services to its clients for 39 years. The CLIA laboratory and sample acquisition programs with major hospitals and medical research institutions help to facilitate the rapid development and commercialization of laboratory developed tests. Synovasure®, the company's laboratory developed test for periprosthetic joint infection, developed with Zimmer, has been available for sale since September 2013. Additional tests for other disease states and for use as companion diagnostics are being developed. CD Diagnostics aims to commercialize products through strategic alliances with corporate partners who are market leaders in their industry.
May 2014CD Diagnostics Brings High-Tech Jobs to Delaware
June 23-26, 2014
July 27-31, 2014
August 8-9, 2014